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Abstract 
The beneficial effects of hydrogen gas inhalation during ex vivo lung 
perfusion on donor lungs obtained after cardiac death in pig lung 
transplantation model 
 
Seokjin Haam 
Department of Medicine 
The Graduate School, Yonsei University 
Directed by Professor Hyo Chae Paik 
INTRODUCTION: Lung transplantation (LTx) is the optimal 
treatment for end-stage lung diseases. However, a shortage of donor 
lungs is the major obstacle to LTx. To overcome this problem, the 
donation after cardiac death (DCD) lungs are used. The use of DCD 
lungs brings several disadvantages including longer warm ischemic 
times compared to brain death donor lung, and absence of objective 
methods such as arterial blood gas analysis (ABGA) and pulmonary 
artery pressure to evaluate DCD lung function. Ex Vivo Lung Perfusion 
(EVLP) is a system that circulates normothermic perfusate into 
procured lungs, allowing for improved lung function and lung 
assessment. In this study, we investigated whether ventilation with 
hydrogen gas during EVLP improves DCD lung function, and whether 
this effect persists after actual transplantation. 
MATERIALS and METHODS: 10 pigs were randomly divided into 
control group (n = 5) and hydrogen group (n = 5). After fibrillation by 
electric shock, no further treatment was administered in order to induce 
warm ischemic injury for 1 hour. Next, the lung was procured and 
EVLP was applied for 4 hours. During EVLP, the control group was 
given room air for respiration while the hydrogen group was given 2% 
hydrogen gas. After EVLP, the left lung graft was orthotopically 
2 
transplanted into the recipient pig and reperfused for 3 hours. During 
EVLP and reperfusion, the functional parameters and ABGA were 
measured every hour. Superoxide dismutase (SOD), heme oxygenase 
(HO)-1, interleukin (IL)-6, IL-10, tumor necrosis factor-alpha (TNF-α) 
and NOD-like receptor protein 3 (NLRP3) were evaluated in lung 
tissue after reperfusion. Pathological evaluations were performed using 
lung injury severity (LIS) scores and the degree of apoptosis was 
evaluated by terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay. Wet/dry ratio was also measured.  
RESULTS: During EVLP, pulmonary vascular resistance (PVR), and 
peak airway pressure (PAP) were lower in the hydrogen group, but 
lung compliance (LC) was lower in the control group. After LTx, 
oxygen capacity (p = 0.033), LC (p = 0.002), and PAP (p = 0.020) were 
significantly better in the hydrogen group. The expressions of SOD (p 
= 0.022) and HO-1 (p = 0.047) were significantly higher in the 
hydrogen group. The expressions of IL-6 (p = 0.024) and NLRP3 (p = 
0.042) were higher in the control group, but IL-10 (p = 0.037) was 
higher in the hydrogen group. LIS score and the number of apoptotic 
cells were higher, and the degree of pulmonary edema was more severe 
in the control group than in the hydrogen group (LIS score: 2.2 ± 0.2 vs 
0.7 ± 0.2; number of apoptotic cells: 3.4 ± 1.6 vs 2.1 ± 0.4; Wet/dry 
ration: 2.833 ± 0.354 vs 1.766 ± 0.078, respectively). 
CONCLUSION: Hydrogen gas inhalation during EVLP improved 
DCD lung function via reduction of inflammation and apoptosis, and 
this effect persisted after LTx. Hydrogen gas inhalation during EVLP 
may increase the utilization of DCD lungs.  
 
_________________________________________________________ 
Key Words: Hydrogen, Warm ischemic injury, Donation after cardiac 
death, Ex vivo lung perfusion, Lung transplantation, Lung preservation. 
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I. INTRODUCTION 
 Lung transplantation (LTx) is the most effective treatment for 
end-stage lung diseases, but a shortage of donor lungs results in 
increase waitlist mortality. To overcome this problem, the donation 
after cardiac death (DCD) lungs started being used ever since Steen, et 
al. first reported a successful LTx using a DCD lung.
1
 
 Despite its promising potential, DCD lung brings several 
disadvantages compared to heart beating donor lung.  First, the longer 
warm ischemic times of DCD lungs might deteriorate lung graft 
function. Moreover, donor-to-donor variations in warm ischemic times 
hinder the accurate prediction of peri-transplant DCD lung function.
2
 
4 
Secondly, because there is no blood supply to DCD organs, it is 
impossible to accurately assess DCD lung function using common 
diagnostic tools such as arterial blood gas analysis (ABGA). 
Nevertheless, several institutions have performed successful LTx 
procedures using DCD lungs,
3,4
 and the number of cases is increasing. 
 Ex vivo lung perfusion (EVLP) is a system that perfuses 
normothermic perfusate into procured lungs and facilitates mechanical 
ventilation, thus mimicking an environment similar to that found in 
vivo. This allows for more accurate lung assessment and improved lung 
function. Steen, et al. reported a case of successful LTx in which EVLP 
was applied to evaluate the pre-transplant condition of a DCD lung.
1
 
However, EVLP itself can lead to organ damage because of coagulation 
abnormalities and inflammation.
5
 Moreover, EVLP alone cannot 
improve the graft function pathologically.
6
 Therefore, to improve graft 
function, various modalities have been applied in combination with the 
EVLP system. 
 Hydrogen gas has anti-oxidant and anti-inflammatory effects. 
The therapeutic anti-oxidant effect of hydrogen have been 
demonstrated in ischemic reperfusion-injured organs, including the 
brain, the heart, the liver, and the intestines.
7
 In recent reports, it was 
5 
demonstrated that hydrogen gas inhalation during EVLP could improve 
the function of DCD lungs in a pig model,
8
 and result in better post-
transplant graft function in a rat LTx model.
9
 
 The aim of this study was to investigate whether hydrogen gas 
inhalation during EVLP improves the function of donor lungs procured 
from a pig DCD model, and to evaluate whether this effect persists 
after LTx. 
 
 
II. MATERIALS AND METHODS 
  1. Animals 
 Female Yorkshire pigs (XP Bio, Anseong, Korea) weighing 40 
kg were used in this study. All surgical procedures and animal care 
were carried out in accordance with the Laboratory Animals Welfare 
Act, the Guide for the Care and Use of Laboratory Animals, and the 
Guidelines and Policies for Swine Survival Surgery; provided by the 
Institutional Animal Care and Use Committee (IACUC) of the Yonsei 
University Health System.  
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2. Donor lung procurement 
 Donor lung procurement and EVLP technique were performed 
as reported previously.
8
 
 Ten pigs were randomly divided into control group (n = 5) and 
hydrogen group (n = 5). In the control group, lung grafts were 
ventilated using only room air during EVLP, while in the hydrogen 
group, they were ventilated with 2% hydrogen. 
 The pigs were sedated intramuscularly with 5 mg/kg of 
tiletamine/zolazepam (Zoletil;Virbac, Carros, France) and 2 mg/kg of 
xylazine (Rompun; Bayer, Seoul, Korea). Endotracheal intubation was 
performed using an 8-mm diameter tube, and a Foley catheter was 
inserted. The pigs were then anesthetized with isoflurane (Forane; JW 
Pharmaceutical, Seoul, Korea). The ventilator was set in a volume 
control mode with a tidal volume of 10 mL/kg, a positive end-
expiratory pressure (PEEP) of 5 cmH2O, a respiratory rate of 16–
18/min, and a fraction of inspired oxygen (FiO2) of 0.5. After 
fibrillation was induced by a 9-V electrical shock through the vertical 
subxiphoid incision, the pigs were left to progress to cardiac arrest. 
Cardiac arrest was defined as the state when the difference between 
systolic and diastolic pressure was zero, and when there was an absence 
7 
of electrical activity in the electrocardiogram. After declaration of 
cardiac death, the pigs were left untouched at room temperature for 1 h; 
however, mechanical ventilation was maintained with the 
aforementioned settings. 
 One hour after declaration of cardiac death, the sternum and 
pericardium were opened and 15,000 U of heparin (JW Pharmaceutical, 
Seoul, Korea) was injected into the main pulmonary artery (MPA). 
Cardiac massage was performed to circulate the heparin into the lung. 
A Prolene 4-0 (Ethicon, Peterborough, Canada) purse string suture was 
placed in the MPA followed by insertion of a 20 Fr. Foley catheter. 
After ligating the superior and inferior vena cava, the aorta was cross-
clamped, and the left atrial appendage was incised. Lung preservation 
solution (Perfadex; Vitrolife, Göteborg, Sweden) was flushed (60 
mL/kg at 4°C) into the MPA from a height of 30 cm. After the flush, the 
heart was excised and a retrograde perfusion of 500 mL of Perfadex 
into the left atrium (LA) was performed. While maintaining airway 
pressure at 15 cmH2O and a FiO2 of 0.5, the trachea was clamped and 
the lungs were excised to keep the lungs inflated. A LA cuff was 
designed to match the size of the funnel-shaped LA cannula (Vitrolife) 
and was secured with a Prolene 4-0 suture. A pulmonary artery (PA) 
8 
cannula (Vitrolife) was inserted into the MPA and tied with heavy silk 
(Ethicon). A tracheal tube was placed in the airway to prevent collapse 
of the lungs. 
 
  3. Preparation of the EVLP system 
 The EVLP system was prepared and managed in accordance 
with the Toronto protocol.
10
 The EVLP system consisted of a 
mechanical ventilator (Hamilton-C2, Hamilton Medical AG, Bonaduz, 
Switzerland) and a centrifugal pump (Rotaflow, Maquet 
Cardiopulmonary AG, Hirrlingen, Germany) to circulate perfusate 
through the system. Mixed gas (6% O2, 8% CO2, and 86% N2) was 
administered while the perfusate passed through the membrane 
oxygenator (Quadrox PLS oxygenator, Maquet Cardiopulmonary AG); 
this allowed de-oxygenation before the perfusate was re-circulated into 
the PA. A leukofilter was placed immediately before entry to the PA and 
a heat exchanger (HU 35, Maquet Cardiopulmonary AG) was 
connected to the membrane oxygenator. 
 The perfusate comprised 1500 mL of Steen solution (Vitrolife) 
mixed with 10,000 U of heparin, 500 mg of cefazolin (Yuhan 
Corporation, Seoul, Korea), and 500 mg of methylprednisolone (Dong-
9 
A Pharmaceutical, Seoul, Korea). 
 
  4. Management of the EVLP system 
 Lungs were placed in XVIVO chamber (Vitrolife) and both the 
PA and the LA cannulas were connected to this system, while ensuring 
that no air entered into the circulation. Circulation was initiated slowly, 
at a rate of 150 mL/min at 20°C, and then the perfusate temperature 
was gradually increased to 37°C over a period of 30 min. After 20 min 
of circulation, ventilation was initiated and the perfusion flow rate was 
gradually increased. The ventilator settings comprised a tidal volume of 
7 mL/kg, a respiratory rate of 7/min, and a PEEP of 5 cmH2O. During 
EVLP, lungs in the control group were ventilated with room air (FiO2 
of 0.21), while those in the hydrogen group were ventilated with 2% 
hydrogen mixed with room air (FiO2 of 0.21). Simultaneously, 0.5 
L/min of mixed gas was insufflated into the membrane oxygenator and 
gas flow was adjusted to maintain a PCO2 between 35 and 45 mmHg. 
As the perfusate temperature reached 37°C and 40% of the expected 
cardiac output was attained, the perfusion flow rate was increased to 
1500 mL/min.  
 During the entire period of EVLP, LA and PA pressure was 
10 
maintained at between 3 and 5 mmHg, and 10 and 15 mmHg, 
respectively, by adjusting the reservoir level. In order to keep the 
contents of the perfusate as constant as possible, 100 mL of Steen 
solution were exchanged every hour. 
 
  5. Termination of EVLP 
 At the end of EVLP, circulation was stopped and PA and LA 
cannulas were disconnected from the EVLP circuit. Next, Perfadex was 
flushed (60 mL/kg at 4°C) into the PA cannula from a height of 30cm. 
During this procedure, ventilation was maintained with a tidal volume 
of 7 mL/kg, a respiratory rate of 7/min, a PEEP of 5 cmH2O, and a FiO2 
of 0.5. After infusion of Perfadex solution, the trachea was clamped to 
keep the lungs inflated. PA and LA cannulas were removed and the lung 
was kept in Perfadex solution at 4°C. 
 
  6. LTx procedure 
 Anesthesia of the recipient was induced as described above for 
the donor. A left thoracotomy was performed through the fourth 
intercostal space. The pulmonary hilum was dissected and the left 
azygos vein was isolated from the LA and ligated. The inferior 
11 
pulmonary ligament was dissected. PA and PV were ligated and 
divided. The left main bronchus was clamped and excised distally. The 
left lung was extracted from the left thoracic cavity. The donor lung 
was trimmed for left LTx. Bronchial anastomosis was performed with a 
running 3-0 Prolene suture, and PA anastomosis was performed with a 
continuous 5-0 Prolene suture. The LA of the donor was anastomosed 
to the left appendage of the recipient with a running 4-0 Prolene suture. 
After re-inflation of the transplanted lung, the PA clamp was removed 
gradually, and the lung was de-aired through the LA anastomosis. 
 
  7. Evaluation of lung function during EVLP 
 Lung functional parameters were measured every hour during 
EVLP. Ten minutes prior to each measurement, an airway recruitment 
maneuver was performed twice to an airway pressure of 25 mmHg, at 
FiO2 of 1.0, in order to avoid atelectasis. 
 The measured functional parameters were oxygen capacity 
(OC, [LA perfusate PO2−PA perfusate PO2]/FiO2) calculated using 
ABGA, pulmonary vascular resistance (PVR, [PA pressure−LA 
pressure] × 80/pulmonary artery flow), lung compliance and peak 
airway pressure (PAP).  
12 
  8. Evaluation of lung function after LTx 
 At reperfusion, two 16G catheters were inserted into the 
ascending aorta and the MPA, respectively, and systemic and PA 
pressures were measured continuously. The ventilator setting was a 
volume control mode with a tidal volume of 10 mL/kg, a PEEP of 5 
cmH2O, a respiratory rate of 12/min, and a FiO2 of 0.5. ABGA was 
measured every hour during reperfusion. Ten minutes prior to each 
measurement, the recruitment maneuver was performed twice to an 
airway pressure of 25 mmHg, at FiO2 of 1.0. At the end of 3-hour 
reperfusion, sternotomy was performed and the right PA was clamped 
to evaluate only left lung function. FiO2 was maintained at 1.0. After 15 
minutes, ABGA was performed and the left lung was removed.  
 Lung specimens were excised for biological marker analysis, 
pathology and wet/dry ratios from the left lower lobe posterior portion. 
Superoxide dismutase (SOD), heme oxygenase (HO)-1, interleukin 
(IL)-6, IL-10, tumor necrosis factor-alpha (TNF-α) and NLRP3 (NOD-
like receptor protein 3)/NALP3 (NACHT, LRR and PYD domains-
containing protein 3) were measured by western blot analysis. 
Antibodies against SOD, HO-1, IL-6, 10, and TNF-α were 
manufactured by Abcam and antibodies against NLRP3/NALP3 by 
13 
R&D.  
 Specimens were prepared for pathological evaluation by 
fixation in 10% buffered formalin and by hematoxylin and eosin 
staining. Pathological assessments were performed by a blinded 
pathologist in accordance to the lung injury severity (LIS) score.
11
 This 
score is based on four indicators: (i) alveolar capillary congestion, (ii) 
hemorrhage, (iii) infiltration or aggregation of neutrophils in the air 
space or the vessel wall and (iv) thickness of the alveolar wall/hyaline 
membrane formation.  Depending on the severity of the respective 
indicators, a score between 0 (minimal damage) and 4 (maximal 
damage) was assigned, and the sum of the scores was averaged to 
compare the results between the two groups. 
 Apoptotic cells were detected using the terminal 
deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. 
Stained cells were counted by evaluating five fields per sample, and the 
mean of the five values was calculated. 
 The wet/dry weight ratios were calculated based on the weight 
difference of specimens before and after storage at 80°C for 72 h. 
 
 
14 
  9. Statistical analyses 
 Results were expressed as the mean ± standard error of the 
mean. For comparison of the lung functional parameters, such as OC, 
PVR, and PAP, repeated measures analysis of variance (ANOVA) was 
performed. A Mann–Whitney test was performed for the comparison of 
other variables (western blots, the wet/dry ratio, and the LIS). All 
statistical analyses were performed using SPSS software version 21.0 
(IBM, Somers, NY, USA) and p values <0.05 were considered 
statistically significant. 
 
 
III. RESULTS 
  1. Lung function during EVLP 
 OC, a measurement of the oxygen transfer capacity of the lung, 
was not different between the two groups (Fig 1A). PVR, which 
increases as lung function deteriorates, was higher in the control group 
than in the hydrogen group over the entire duration of the EVLP, 
although the difference was not statistically significant (Fig 1B). There 
was a statistically significant difference in lung compliance between the 
two groups (p = 0.031) (Fig 1C). PAP was not different between the 
15 
two groups over the entire duration of the EVLP, but it was 
significantly lower in the hydrogen group at the 4-hour time point (p = 
0.027) (Fig 1D). 
 
Figure 1. Functional parameters during Ex Vivo Lung 
Perfusion. A. Oxygen capacity (OC), B. Pulmonary 
vascular resistance (PVR), C. Lung compliance (LC), 
D. Peak airway pressure (PAP). Although OC and 
PVR were not different between the two groups over 
time, PVR tended to increase in the control group. LC 
was significantly higher in the hydrogen group. PAP 
was not different between the two groups over time, 
but it was lower in the hydrogen group at the 4-hour 
time point (*p = 0.027).  Dotted line; control group, 
solid line; hydrogen group. 
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2. Lung function after LTx 
    (A) Functional parameters 
 OC was better in the hydrogen group than in the control group 
over the entire duration of reperfusion (p = 0.033). Especially, after 
right PA clamp, OC decreased suddenly in the control group (Fig 2A). 
Lung compliance (p = 0.002) and PAP (p = 0.020) were also 
significantly better in the hydrogen group than in the control group (Fig 
2B, 2C). 
 
 
Figure 2. Functional parameters after lung 
transplantation. A. Oxygen capacity (OC), B. Lung 
compliance (LC), C. Peak airway pressure (PAP). The 
control group showed a decrease in OC and LC, and an 
increase in PAP over time. However, the hydrogen group 
showed relatively stable values. All parameters had 
statistical significance. Dotted line; control group, solid 
line; hydrogen group. 
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    (B) Biological markers 
 The expressions of SOD (p = 0.022) and HO-1 (p = 0.047) 
were higher in the hydrogen group (Fig 3). The expression of IL-6 
within the lung tissue was significantly lower in the hydrogen group 
than in the control group (p = 0.024) (Fig 4A). The expression of IL-10 
was significantly higher in the hydrogen group (p = 0.037) (Fig 4B). 
However, there was no difference in TNF-α (Fig 4C). The expression of 
NLRP3 was significantly higher in the control group than the hydrogen 
group (p = 0.042) (Fig 4D).  
 
Figure 3. The effects of hydrogen on the expression of 
anti-oxidases in lung grafts after lung transplantation. A. 
The expression level of superoxide dismutase (SOD). B. 
The expression level of heme oxygenase (HO) -1. The 
expressions of SOD and HO-1 were significantly higher 
in the hydrogen group.  
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Figure 4. The effects of hydrogen on inflammation of 
lung grafts after lung transplantation. A. The expression 
level of interleukin (IL)-6, B. IL-10, C. Tumor necrosis 
factor (TNF)-α, D. NOD-like receptor protein 3 (NLRP3). 
The expression level of proinflammatory cytokine (IL-6) 
was higher in the control group, but the expression level 
of anti-inflammatory cytokine (IL-10) was higher in the 
hydrogen group. The expression of NLRP3, a regulator 
of inflammation and apoptosis was lower in the hydrogen 
group. 
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3. Lung injury severity score 
 The LIS scores were 2.2 ± 0.2 in the control group and 0.7 ± 
0.2 in the hydrogen group, indicating that the degree of lung injury was 
the lower in hydrogen group (Fig 5). 
 
 
Figure 5. Pathologic findings in lung grafts (H&E, x100). 
A. Control group. Severe pulmonary edema was found, 
and many inflammatory cells were accumulated in the 
lung grafts of the control group. B. Hydrogen group. 
Alveolar structures were maintained relatively well and 
no pulmonary edema was found in the hydrogen group.  
 
 
  4. TUNEL assay 
 The numbers of apoptotic cells per field as assessed by TUNEL 
were 3.4 ± 1.6 in the control group and 2.1 ± 0.4 in the hydrogen group 
(Fig 6). 
20 
 
Figure 6. TUNEL assay in lung grafts (x400). A. Control 
group. B. Hydrogen group. Lung grafts of the control 
group had more apoptotic cells than those of the 
hydrogen group. There were more inflammatory cells 
and edema in lung grafts of the control group. Black 
arrow; apoptotic cell. 
 
 
  5. Wet/dry ratio 
 The wet/dry ratio was 2.833 ± 0.354 in the control group and 
1.766 ± 0.078 in the hydrogen group, indicating that the extent of 
pulmonary edema was the lower in the hydrogen group. 
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IV. DISCUSSION 
 DCD lung is a good solution to manage the shortage of brain 
death donor lungs in the LTx. Although the safety of LTx using DCD 
lungs has been repeatedly reported,
1,12
 the relatively longer warm 
ischemic times of DCD lungs might deteriorate lung graft function. In 
this study, we demonstrated that hydrogen gas inhalation during EVLP 
in pig DCD lung model improved DCD lung function by down-
regulating inflammatory and apoptotic markers, and this effect 
persisted after LTx. 
  EVLP maintains lung function by providing oxygen and 
appropriate nutrients necessary in graft survival to the procured lung, 
enabling an objective evaluation of the lung condition before 
transplantation.
10
 In addition, various modified techniques can be 
applied to improve the lung function even if the lung function is 
marginal.
13,14
  
 However, there is still controversy on whether EVLP itself can 
improve lung function or change the pathology as it can induce lung 
damage associated with the mechanical ventilator or pump.
6
 Therefore, 
in order to improve lung function further, additional procedures such as 
nitric oxide (NO) ventilation, surfactant injections, or gene therapy 
22 
have been performed simultaneously during EVLP.
15-17
 
 Recently, there have been animal study results reporting that 
hydrogen gas inhalation before lung procurement for lung transplant 
decreases ischemic reperfusion injury and primary graft dysfunction 
after transplantation.
18,19
 Another study reported that hydrogen gas 
inhalation decreases EVLP-related adverse effects in a rat model, 
thereby improving the graft function after transplantation.
9
 We also 
demonstrated previously that hydrogen gas inhalation during EVLP 
improved the lung function in a pig DCD lung model.
8
 The aim of this 
study was to investigate whether such protective effects of hydrogen 
gas during EVLP can continue after LTx and to elucidate the 
mechanisms of the positive effects of hydrogen inhalation. 
 In the evaluation of lung function during EVLP, OC was not 
significantly different, which was in agreement with our previous 
result.
8
 The hydrogen group exhibited significantly better lung 
compliance than the control group during the whole period of the 
EVLP, although PAP was statistically lower only at the 4-hour time 
point. Such a superior function of lung graft during EVLP could be 
maintained after LTx. All of OC, lung compliance and PAP reflected 
the better lung function statistically.  
23 
In the pathologic evaluation, the degree of LIS was more 
severe in the control group than in the hydrogen group. The lower 
wet/dry ratio in the hydrogen group demonstrated that hydrogen gas 
inhalation may also play a role in reducing pulmonary edema.  
 Generally, the mechanisms underlying the beneficial effects of 
hydrogen involve the action of anti-oxidases
20
 as well as anti-
inflammation
21
 and anti-apoptosis.
22
 Firstly, to demonstrate the anti-
oxidant effect of hydrogen, we evaluated the expression levels of SOD 
and HO-1 in lung tissue after LTx. Zhai, et al. reported that hydrogen 
could activate NF-E2-related factor 2 (Nrf2), the protein that regulates 
the expression of anti-oxidant proteins that protect against oxidative 
damage. Activated Nrf2 initiates the anti-oxidative pathway via 
production of anti-oxidants such as SOD.
23
 Meanwhile, HO-1, a critical 
downstream molecule of Nrf2, is induced by oxidative stresses such as 
hyperoxia and hypoxia. HO-1 can reduce ischemic reperfusion injury 
(IRI) after organ transplantation.
24,25
 In accordance with previous 
reports, the present study showed the elevated expression levels of 
SOD and HO-1.  
Secondly, to demonstrate the anti-inflammatory effect of 
hydrogen, we measured the expression levels of pro- and anti-
24 
inflammatory cytokines (including IL-6, IL-10 and TNF-α) and NALP3 
in the transplanted lung tissues. These results showed that IL-6, a pro-
inflammatory cytokine, was over-expressed in the control group. On 
the contrary, the expression level of IL-10, an anti-inflammatory 
cytokine was higher in the hydrogen group. NALP3, a component of 
inflammasome, was over-expressed in the hydrogen group. Therefore, 
we could confirm that hydrogen inhalation might exert an anti-
inflammatory effect by inducing anti-inflammatory cytokines and 
inhibiting pro-inflammatory cytokines. 
Thirdly, we evaluated the effect of hydrogen on apoptosis using 
TUNEL assay. The number of apoptotic cells was higher in the control 
group. Various stressful conditions induce apoptosis, among which the 
accumulation of reactive oxygen species is a major cause of the 
apoptotic process.
26
 Because hydrogen gas can selectively reduce the 
most toxic reactive oxygen species such as hydroxyl radicals and 
peroxinitrate anions,
27
 we think that hydrogen gas exerts an anti-
apoptotic effect in ischemia reperfusion injured lung grafts. 
  Although this study showed that hydrogen inhalation during 
EVLP in DCD lungs could improve lung function after LTx, 
reperfusion time was relatively short to evaluate the effect of hydrogen 
25 
on primary graft dysfunction and graft rejection. 
 
 
V. CONCLUSION 
 This study confirmed hydrogen gas ventilation during EVLP of 
DCD lungs improves lung function through the action of anti-oxidases, 
anti-inflammation, and anti-apoptosis, and such beneficial effects 
persist after actual transplantation. Therefore, the application of 
hydrogen gas inhalation during EVLP before DCD lung transplantation 
is expected to help solve the shortage of brain death donor lungs.  
 
 
 
  
26 
REFERENCES 
1. Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. 
Transplantation of lungs from a non-heart-beating donor. Lancet 
2001;357:825-9. 
2. Mulloy DP, Stone ML, Crosby IK, Lapar DJ, Sharma AK, Webb 
DV, et al. Ex vivo rehabilitation of non-heart-beating donor 
lungs in preclinical porcine model: delayed perfusion results in 
superior lung function. J Thorac Cardiovasc Surg 
2012;144:1208-15. 
3. De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, Vos 
R, Meers C, Wauters S, et al. Early outcome after lung 
transplantation from non-heart-beating donors is comparable to 
heart-beating donors. J Heart Lung Transplant 2009;28:380-7. 
4. Dark JH. Lung transplantation from the non-heart beating 
donor. Transplantation 2008;86:200-1. 
5. Peek GJ, Firmin RK. The inflammatory and coagulative 
response to prolonged extracorporeal membrane oxygenation. 
ASAIO J 1999;45:250-63. 
6. Wallinder A, Ricksten SE, Silverborn M, Hansson C, Riise GC, 
Liden H, et al. Early results in transplantation of initially 
27 
rejected donor lungs after ex vivo lung perfusion: a case-control 
study. Eur J Cardiothorac Surg 2014;45:40-4; discussion 4-5. 
7. Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances 
in hydrogen research as a therapeutic medical gas. Free Radic 
Res 2010;44:971-82. 
8. Haam S, Lee S, Paik HC, Park MS, Song JH, Lim BJ, et al. The 
effects of hydrogen gas inhalation during ex vivo lung perfusion 
on donor lungs obtained after cardiac deathdagger. Eur J 
Cardiothorac Surg 2015;48:542-7. 
9. Noda K, Shigemura N, Tanaka Y, Bhama J, D'Cunha J, 
Kobayashi H, et al. Hydrogen preconditioning during ex vivo 
lung perfusion improves the quality of lung grafts in rats. 
Transplantation 2014;98:499-506. 
10. Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, 
Anraku M, et al. Technique for prolonged normothermic ex 
vivo lung perfusion. J Heart Lung Transplant 2008;27:1319-25. 
11. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy 
MC, et al. CXCR2 is critical to hyperoxia-induced lung injury. J 
Immunol 2004;172:3860-8. 
12. Fernandez E, Calatayud J, Jarabo JR, Hernando F, Rodriguez O, 
28 
Gomez AM, et al. Profitability of our lung retrieval program 
from non heart beating donors. Eur J Cardiothorac Surg 
2009;35:287-91; discussion 91-2. 
13. Wierup P, Haraldsson A, Nilsson F, Pierre L, Schersten H, 
Silverborn M, et al. Ex vivo evaluation of nonacceptable donor 
lungs. Ann Thorac Surg 2006;81:460-6. 
14. Egan TM, Haithcock JA, Nicotra WA, Koukoulis G, Inokawa 
H, Sevala M, et al. Ex vivo evaluation of human lungs for 
transplant suitability. Ann Thorac Surg 2006;81:1205-13. 
15. Dong BM, Abano JB, Egan TM. Nitric oxide ventilation of rat 
lungs from non-heart-beating donors improves posttransplant 
function. Am J Transplant 2009;9:2707-15. 
16. Inci I, Ampollini L, Arni S, Jungraithmayr W, Inci D, Hillinger 
S, et al. Ex vivo reconditioning of marginal donor lungs injured 
by acid aspiration. J Heart Lung Transplant 2008;27:1229-36. 
17. Cypel M, Liu M, Rubacha M, Yeung JC, Hirayama S, Anraku 
M, et al. Functional repair of human donor lungs by IL-10 gene 
therapy. Sci Transl Med 2009;1:4ra9. 
18. Kawamura T, Huang CS, Peng X, Masutani K, Shigemura N, 
Billiar TR, et al. The effect of donor treatment with hydrogen on 
29 
lung allograft function in rats. Surgery 2011;150:240-9. 
19. George TJ, Arnaoutakis GJ, Beaty CA, Jandu SK, Santhanam L, 
Berkowitz DE, et al. Inhaled hydrogen sulfide improves graft 
function in an experimental model of lung transplantation. J 
Surg Res 2012;178:593-600. 
20. Buchholz BM, Kaczorowski DJ, Sugimoto R, Yang R, Wang Y, 
Billiar TR, et al. Hydrogen inhalation ameliorates oxidative 
stress in transplantation induced intestinal graft injury. Am J 
Transplant 2008;8:2015-24. 
21. Gharib B, Hanna S, Abdallahi OM, Lepidi H, Gardette B, De 
Reggi M. Anti-inflammatory properties of molecular hydrogen: 
investigation on parasite-induced liver inflammation. C R Acad 
Sci III 2001;324:719-24. 
22. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, et al. 
Hydrogen therapy reduces apoptosis in neonatal hypoxia-
ischemia rat model. Neurosci Lett 2008;441:167-72. 
23. Zhai X, Chen X, Shi J, Shi D, Ye Z, Liu W, et al. Lactulose 
ameliorates cerebral ischemia-reperfusion injury in rats by 
inducing hydrogen by activating Nrf2 expression. Free Radic 
Biol Med 2013;65:731-41. 
30 
24. Lee PJ, Camhi SL, Chin BY, Alam J, Choi AM. AP-1 and STAT 
mediate hyperoxia-induced gene transcription of heme 
oxygenase-1. Am J Physiol Lung Cell Mol Physiol 
2000;279:L175-82. 
25. Maines MD. The heme oxygenase system: a regulator of second 
messenger gases. Annu Rev Pharmacol Toxicol 1997;37:517-
54. 
26. Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive 
oxygen species (ROS) in apoptosis induction. Apoptosis 
2000;5:415-8. 
27. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki 
K, Yamagata K, et al. Hydrogen acts as a therapeutic 
antioxidant by selectively reducing cytotoxic oxygen radicals. 
Nat Med 2007;13:688-94. 
  
 
  
31 
APPENDICES 
LTx = lung transplantation; DCD = donation after cardiac death; 
ABGA = arterial blood gas analysis; EVLP = Ex Vivo Lung Perfusion; 
IL = interleukin; TNF-α = tumor necrosis factor-alpha; NLRP3 = NOD-
like receptor protein 3; LIS = lung injury severity; PVR = pulmonary 
vascular resistance; PAP = peak airway pressure; LC = lung 
compliance; OC = oxygen capacity  
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Abstract 
돼지의 심장사후 기증 폐 모델에서 체외폐관류장치 적용 시 
수소기체의 흡입이 이식 후 폐 기능에 미치는 영향 
 
지도교수 백 효 채 
 
연세대학교 대학원 의학과 
함 석 진 
 
서론: 폐 이식은 말기 폐질환에 효과적인 치료법이지만 공여 폐의 
부족으로 인해 시행에 제한을 받고 있으며, 이러한 문제를 
극복하기 위해 최근 심장사후 기증(Donation after cardiac death; 
DCD) 폐를 이용하기도 한다. 그러나, DCD 폐는 몇 가지 단점을 
가지고 있는데, 뇌사 기증 폐에 비해 필연적으로 온열허혈손상 
시간이 길다는 점과 동맥혈 검사나 폐혈관압과 같은 폐 기능을 
평가할 수 있는 객관적인 지표가 없다는 점이다. 한편, 
체외폐순환장치(Ex Vivo Lung Perfusion; EVLP)는 체외로 적출된 
폐에 정상체온의 관류액을 순환시켜 폐 기능의 회복을 돕고 평가할 
수 있게 하는 장치다. 본 연구에서는 EVLP 를 적용하면서 동시에 
수소 기체를 호흡시키는 것이 폐 기능을 향상 시킬 수 있는지 
알아보고, 그 효과가 이식 후에도 지속되는지 살펴보고자 하였다. 
재료 및 방법: 10 마리의 돼지를 5 마리씩 각각 대조군과 
실험군으로 나누고, 전기자극으로 심실세동을 유발시켜 심장을 
정지시킨 후, 1 시간 동안 실온에 방치함으로써 온열허혈손상을 
받도록 하였다. 이후 폐를 적출하여 4 시간 동안 EVLP 를 
적용시켰으며 이때 대조군은 공기를 이용하여, 실험군은 2%의 수소 
기체를 이용하여 인공 호흡하였다. EVLP 적용 후 좌측 폐를 
적출하여 수혜돼지에 정위이식하고 3 시간 동안 재관류 되도록 
하였다. EVLP 와 재관류 시 매시간 기능적 지표들과 동맥혈 검사를 
시행하였다. 이후 좌측 폐를 적출하여 조직 내 Superoxide 
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dismutase (SOD), heme oxygenase (HO)-1, interleukin (IL)-6, 
IL-10, tumor necrosis factor-alpha (TNF-α) and NOD-like 
receptor protein 3 (NLRP3) 의 발현 정도를 측정하였다. Lung 
injury severity (LIS) scores 를 계산하여 조직학적 손상 정도를 
측정하였고 TUNEL assay 를 시행하여 세포자멸사정도를 평가하였다. 
또한, wet/dry 비를 측정하여 폐부종 정도를 평가하였다. 결과: 
EVLP 시행 중 폐혈관저항과 기도내압, 폐순응도는 실험군에서 
낮았으며, 이식 후에도 산소교환능 (p = 0.033), 폐순응도 (p = 
0.002), 기도내압(p = 0.020)이 통계적으로 유의하게 실험군에서 
양호하였다. 조직 내 SOD (p = 0.022) 와 HO-1 (p = 0.047)의 발현 
정도는 실험군에서 통계적으로 유의하게 높았고, IL-6 (p = 
0.024)와 NLRP3 (p = 0.042) 는 대조군에서 높았으나, IL-10 (p = 
0.037)은 실험군에서 높았다. LIS score (대조군: 실험군 = 
2.2±0.2: 0.7±0.2)와 자멸사 세포수 (대조군: 실험군  = 
3.4±1.6:2.1±0.4)는 대조군에서 높게 나타났다. 또한, 폐부종의 
정도(Wet/dry 비; 대조군: 실험군 = 2.833±0.354: 
1.766±0.078)도 대조군에서 더욱 심하였다. 결론: EVLP 적용 중 
수소 기체의 흡입은 염증반응과 세포자멸사를 감소시킴으로써 DCD 
폐의 기능을 향상시켰으며, 그 효과는 이식 후에도 지속되었다. 
따라서, 이러한 치료 방법은 DCD 폐의 활용을 더욱 늘릴 수 있을 
것으로 기대된다. 
 
 
 
 
 
_________________________________________________________ 
핵심되는 말: 수소, 온열 허혈 손상, 심장사후 기증, 
체외폐순환술, 폐이식, 폐보존 
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